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ABSTRACT 
Importance 
Pre-test risk estimation is routinely used in clinical medicine to inform further 
diagnostic testing in patients with suspected diseases. The overall characteristics and 
specific determinants of pre-test probability of psychosis onset in subjects undergoing 
clinical high risk (CHR) assessment are unknown. 
Objectives 
To investigate the characteristics and predictors of pre-test probability of psychosis 
onset in subjects undergoing CHR assessment. To develop and then externally 
validate a pre-test risk stratification model. 
Design 
Clinical register-based cohort study. 
Setting 
Subjects were drawn from electronic, real-world, real-time clinical records relating to 
routine mental health care of CHR services in South London NHS Trust. 
Participants 
All non-psychotic subjects referred on suspicion of psychosis risk and assessed by the 
Outreach and Support in South London (OASIS) CHR service from 2002 to 2015.  
Main outcomes and measures 
Primary outcome: pre-test probability of psychosis onset in subjects undergoing CHR 
assessment. Predictors: age, gender, age x gender interaction, ethnicity, 
socioeconomic status, marital status, referral source and referral year.  
Analyses: model development and validation was performed with machine learning 
methods based on Least Absolute Shrinkage and Selection Operator (LASSO) for 
Cox proportional hazards model. 
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Results 
A total of 710 non-psychotic subjects undergoing CHR assessment were included. 
The cumulative six-year pre-test risk of psychosis was 14.55% (95% CI 11.71% to 
17.99%), confirming substantial risk enrichment during the recruitment of subjects 
undergoing CHR assessment. Ethnicity and source of referral were significant 
predictors of pre-test risk enrichment. The predictive model based on these factors 
was externally validated showing moderately good discrimination and sufficient 
calibration. It was used to stratify subjects undergoing CHR assessment into four 
classes of pre-test risk (six-year): low 3.39% (95%CI 0.96% to 11.56%), moderately 
low 11.58% (95%CI 8.10% to 16.40%) moderately high 23.69% (95%CI 16.58% to 
33.20%) and high 53.65% (95%CI 36.78% to 72.46%). 
Conclusions 
Significant risk enrichment occurs before subjects are assessed for a CHR state. The 
ethnicity and source of referral predict pre-test risk enrichment in subjects undergoing 
CHR assessment. A stratification model can identify subjects at differential pre-test 
risk of psychosis. Identification of these subgroups may inform outreach campaigns, 
subsequent testing and optimize psychosis prediction. 
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INTRODUCTION 
The detection of subjects at clinical high risk (CHR) of developing psychosis1 is 
increasingly recognized as an important component of clinical services for early 
psychosis intervention2 (e.g. NICE guidelines3, recent NHS England Access and 
Waiting Time AWT standard2 and DSM-5 diagnostic manual4). Relying solely on the 
CHR signs and symptoms leads to a correct two-year disease prediction in 
approximately one third of cases5. To improve psychosis prediction, several 
prognostic models have been applied to stratify the risk levels of subjects who have 
been assessed on suspicion of psychosis risk and test positive for the CHR criteria6,7.  
 
However, recent evidence suggests that risk enrichment occurs even before subjects 
undergo a CHR assessment (pre-test risk) and are assigned to a test outcome (post-test 
risk, see8). Therefore, the degree of risk associated with meeting CHR criteria 
depends on the variance of pre-test risk enrichment in the subjects being assessed9 
(e.g. lower pre-test risk dilutes the post-test risk10, see also Table 2 in9). The meta-
analytical pre-test risk (within 38 months) of psychosis across eleven independent 
studies conducted worldwide (Europe, North America, Australia, Asia, n=2519) was 
of 15%, with high heterogeneity (95% CI: 9%–24%)11 across sites. The meta-
analytical clinical gain of testing positive for CHR was relatively modest (as indexed 
by a small positive likelihood ratio8 of 1.829) and associated with a 26% risk of 
developing psychosis (within 38 months)9, in line with previous estimates12. Thus, 
pre-test risk enrichment in these samples is substantial and heterogeneous11, 
accounting for the majority (15/26=58%)9 of their actual risk. Unfortunately, 
predictors of pre-test risk enrichment in subjects with suspected CHR are unknown. 
Meta-analytical evidence suggests that the type of recruitment strategies and outreach 
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campaigns may affect pre-test probability in subjects undergoing CHR assessment11. 
On the basis of existing knowledge of risk factors associated with psychosis, age13,14, 
gender13, interaction age x gender13, ethnicity13, socioeconomic status15, marital 
status16 and referral year12 may additionally modulate pre-test risk in subjects 
undergoing CHR assessment. Characterizing and understanding pre-test risk 
enrichment is necessary to optimize psychosis prediction10 and improve the clinical 
practice.  
 
We present here the first original study exploring the characteristics of pre-test 
probability of psychosis onset in a large sample of subjects undergoing CHR 
assessment over a long-term follow-up period. We additionally investigated potential 
predictors of pre-test probability in subjects with a suspected CHR state and 
suggested a clinical pre-test risk stratification model.  
 
METHODS 
Sample 
We included all non-psychotic subjects assessed on suspicion of psychosis risk by the 
Outreach and Support in South London (OASIS) CHR service17. All subjects referred 
to the OASIS in the period January 1, 2002 to December 31, 2015 were initially 
considered eligible. Then, we discharged those who were referred but never assessed 
by the team and those who were already psychotic at baseline. The remaining sample 
was therefore composed of all non-psychotic subjects undergoing a Comprehensive 
Assessment of At Risk Mental State (CAARMS)-based CHR assessment18 at the 
OASIS. Details of the clinical care received at the OASIS team have been described 
elsewhere19. 
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Study measures  
Outcome variable 
The primary outcome of interest for the current study was the cumulative pre-test risk 
of developing psychosis in non-psychotic subjects undergoing a CHR assessment. 
Psychosis onset was defined by the presence of ICD-1020 diagnoses of psychotic 
disorders in the electronic clinical records (see below). Time to diagnosis of a 
psychotic disorder was measured from the date of first referral to OASIS, censored at 
February 1, 2016. 
 
Predictor variables 
The predictors of the pre-test risk in subjects undergoing a CHR assessment were as 
follows: age13, gender13, ethnicity13 (black, white, Asian, Caribbean, mixed and 
other), marital status16 ( married, divorced or separated, single and in a relationship), 
referral year12 (2002–2005, 2006–2010 and 2011–2015), referral source11 (self, carers 
or relatives, schools and colleges, social services or supported accommodations, 
general medical practitioners, community mental health services, inpatient mental 
health services, child and adolescent mental health services, early intervention for 
psychosis services, accident and emergency departments, police and criminal justice 
system and physical health services), socioeconomic status15 (index of multiple 
deprivation, IMD21) and the interaction age x gender13. All predictor data obtained 
were those closest to the time of first referral to OASIS. Antipsychotic exposure 
during follow-up was additionally extracted as confounding factor.  
 
Procedure  
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This was a clinical register-based cohort study. Outcome and predictor measures were 
automatically extracted with the use of the Clinical Record Interactive Search (CRIS) 
tool22 (see eMethods for details on CRIS).  
 
Statistical analysis  
Sociodemographic characteristics of the sample were described with mean and 
standard deviation for continuous variables and absolute and relative frequencies for 
categorical variables. To investigate the characteristics of pre-test risk of psychosis 
onset in subjects undergoing the CHR assessment, we reported its cumulative 
incidence, estimated by the Kaplan–Meier failure function (1  survival)23 and 
Greenwood 95% CIs24. We further used smoothed curves to describe the baseline 
hazard function25, computed with kernel density estimation.  
Model development and validation followed the guidelines of Royston et al26 and was 
performed with a machine learning method that is recommended in the TRIPOD 
checklist27, the Least Absolute Shrinkage and Selection Operator (LASSO) for Cox 
proportional hazards model. LASSO is penalized regression analysis method that 
performs both variable selection and regularization (shrinking the sum of the absolute 
values of the regression coefficients28) in order to enhance the prediction accuracy 
and interpretability of the statistical model it produces. LASSO is particularly 
indicated to control overfitting problems when the number of events is small29. We 
used k-fold cross-validation (repeated 100 times) to find the optimal value of 
shrinkage parameter λ that gives the minimum mean cross-validated error. Because of 
significant sociodemographic differences between the borough of Lambeth and the 
other boroughs (see table 1 and figure 2 and 3 from30) we used nonrandom split-
sample development and external validation27, with the Lambeth cases in the 
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derivation sample and all the other cases in the validation sample. First, the model 
with all the candidate predictors (categorical predictors were split into dummy 
variables) was fitted to the derivation data to estimate the optimal regression 
coefficients. Applying the model selected by LASSO to each case of the derivation 
dataset, we then generated individual prognostic scores, allowing a four-level (defined 
with the 25°, 75°, 95°percentiles) prognostic index (PI) for pre-test probability to be 
developed in the derivation dataset31. The regression coefficients estimated in the 
derivation datasets were then applied to each case in the validation dataset to generate 
prognostic scores and the PI. Model performance was assessed with the calibration 
slope (discrimination, model fit)26, calibration intercept (calibration)32, Kaplan-Maier 
curves for risk groups (discrimination, calibration)26, Harrel’s c-index 
(discrimination)26 and hazard ratios across risk groups (discrimination)26. In a further 
step we updated the model refitting it to the whole sample rerunning the LASSO, and 
we tested the confounding effect of antipsychotic exposure. As a supplementary 
analysis, we additionally reported the risk of psychosis in subjects referred for, but not 
undergoing, a CHR assessment. All analyses were conducted in STATA 13 (STATA 
Corp., TX, USA) and R 3.3.0 (package glmnet version 2.0-5). 
 
RESULTS  
Sociodemographic and clinical characteristics of the sample 
From 2002 to 2015, a total of 1115 subjects were referred to the OASIS clinic for 
CHR assessment. Among them, 125 subjects did not undergo the CHR assessment 
and had no contacts with the OASIS service. An additional 280 subjects were already 
psychotic at baseline (the clinical fate of these subjects is described elsewhere33). A 
final sample of 710 non-psychotic subjects who underwent CHR assessment was used 
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in the current study (Table 1).  
The mean follow-up was of 1472 days (median 1181, range 8-5015). The average age 
was 23 years, with 56% males. Half of the sample was of white ethnicity. The vast 
majority was single. Approximately one third of referrals (34%) came from general 
practitioners. The IMD score was 32% (see eResults 1). Characteristics of the 
derivation and validation datasets are appended in the eTable 1.  
 
Pre-test risk of psychosis in subjects undergoing CHR assessment  
The cumulative incidence (Kaplan–Meier failure function) in the 710 subjects 
undergoing the CHR assessment is depicted in Figure 1. There were 570 subjects at 
risk at 1 year, 445 at 2 years, 370 at 3 years, 308 at 4 years, 260 at 5 years. The 
cumulative pre-test risk of psychosis was 14.55% at six years (95% CI 11.71% to 
17.99%). The Kaplan–Meier survival function and the smoothed hazard function are 
reported in eFigures 1 and 2, respectively. There were 81 events, with the last 
transition observed at day 2192 (i.e. at 6.01 years)(see eResults 2 for the specific 
diagnoses), when 193 subjects were still at risk. The mean time to event was 4376 
days (i.e. 11.98 years, SE = 67 days, 14th centile = 2099 days). 
 
Predictors of pre-test probability in subjects undergoing CHR assessments  
Model development  
The LASSO Cox regression analysis in the derivation dataset selected ethnicity and 
source of referral as predictors of pre-test risk of psychosis onset. The PI showed 
moderately good discrimination in stratifying four groups at differential pre-test risk 
of psychosis. Kaplan-Meier curves and discrimination indexes are detailed in eFigure 
3 and eTable 2. 
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Model validation 
The PI estimated in the validation dataset retained moderately good discrimination 
and sufficient calibration (eFigure 4 and eTable 2). The calibration slope was 0.759 
and not different from 1 (95%CI 0.346 – 1.173), the calibration intercept was -2.405. 
 
Model updating 
The model selected in the development phase, based on ethnicity and source of 
referral, was then updated in the entire sample. The final coefficients and the equation 
to estimate the PI are detailed in the eTable 3. The PI defined four classes of risk that 
were associated with distinctive pre-test probability of psychosis (Figure 2 and Table 
2). Harrel’s c-index in the updated model was 0.70. For descriptive purposes, we also 
reported the cumulative incidence for different source of referral at the time of the last 
failure, 2192 days, in eFigure 5. Ethnicity and source of referrals survived as 
predictors of pre-test risk when antipsychotic exposure was entered in the model (172 
subjects [26%] received antipsychotic treatment during follow-up). 
 
Supplementary analyses are reported in the eFigure 6. 
 
DISCUSSION  
This is the first original study to describe the characteristics of pre-test probability of 
psychosis in a large sample of subjects undergoing CHR assessment and followed up 
over the long term. The cumulative six-year pre-test risk of psychosis was 15%, 
confirming risk enrichment during the recruitment of subjects undergoing CHR 
assessment. Ethnicity and source of referral were significant predictors of pre-test risk 
Page  12 
enrichment. A predictive model was externally validated and used to stratify subjects 
undergoing CHR assessment into four classes of pre-test risk. 
 
The first aim of this study was to address characteristics of the pre-test risk of 
psychosis in subjects referred to high-risk services and undergoing CHR assessment. 
In the largest ‘real world’ sample of subjects undergoing CHR assessment and with 
the longest follow up published to date, we confirmed a 15% pre-test risk of 
developing psychosis at six-year follow up (Figure 1). This risk is well in line with 
previous meta-analytical estimates (which did not include the current data)9 and it is 
35 times higher than the six-year 0.43% risk of psychosis in the local general 
population (Figure 3). Thus, we confirm the substantial risk enrichment occurring 
before the CHR assessment. We also report, for the first time, the pre-test baseline 
hazard function over time (eFigure 2), which indicates a higher risk in the first years 
following referrals and the last transition observed at six years. Such a time course 
parallels the actual risk of transition to psychosis reported in CHR samples5. Of 
relevance, in the supplementary analysis, we additionally found that subjects referred 
to the CHR service but not assessed had a comparable high risk of psychosis (12%) 
and that this level of risk was still higher than in the local general population. This 
may support the case for a more assertive approach to the assessment of subjects 
referred to CHR services34.  
 
The second aim was to investigate potential predictors of pre-test probability of 
psychosis onset in subjects undergoing CHR assessment. We found that pre-test risk 
of psychosis was modulated by ethnicity, with reduced risk in white (HR=0.53, 
eTable 3) or mixed-ethnicity subjects (HR=0.64, eTable 3) and increased risk in 
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Asian (HR=1.23, eTable 3) or Caribbean (HR=1.23, eTable 3) subjects. The impact of 
ethnicity on psychosis incidence has recently been confirmed by meta-analytical 
studies13. There is specific evidence for Asian or Caribbean ethnicity to be associated 
with a higher risk of developing psychosis than white ethnicity (figure 3 from 
reference 13), even after controlling for socioeconomic status35 (we found no effect for 
the IMD score). We also found that source of referrals modulate pre-test risk, with 
reduced risk in self (HR=0.25, eTable 3), carers or relatives (HR=0.27, eTable 3), 
school or colleges (HR=0.628, eTable 3), social services and supported 
accommodation (HR=0.27, eTable 3), child and adolescent mental health services 
(HR=0.62, eTable 3), police and criminal justice system (HR=0.64, eTable 3) 
referrals and increased risk from inpatients mental health units (HR=7.02, eTable 3), 
early intervention for psychosis services (HR=2.43, eTable 3), community mental 
health services (HR=1.36, eTable 3), accident and emergency departments (HR=1.42, 
eTale 3), physical health services referrals (HR=1.16, eTable 3). These findings 
confirm that risk enrichment in subjects undergoing CHR assessment is dependent on 
the adopted recruitment strategies, and therefore, on the referral source36. Subjects 
that had passed through several adult mental health service filters, such as early 
intervention for psychosis services or inpatient units show the highest risk enrichment 
(referrals from child and adolescent mental health services show a reduced pre-test 
risk, in line with studies showing low transition risk in these samples37). In contrast 
referrals outside adult mental health (i.e. self, carer or relatives, schools or colleges, 
police and criminal justice system, social services) diluted risk enrichment11. It is 
possible to speculate that referrals filtered by adult first episode psychosis or inpatient 
mental health services may have accumulated risk factors for psychosis (e.g. 
comorbidities38), with more prominent and functionally impairing symptoms so that 
Page  14 
transition becomes more likely (for a meta-analysis on functional impairments in 
CHR subjects see39). Variability in referral sources may also explain the high 
heterogeneity of pre-test risk that has been observed across CHR services 
wordlwide41,42. Overall, our findings inform outreach campaigns, confirming that 
CHR assessment should be primarily offered to selected samples of subjects “already 
distressed by mental problems and seeking help for them” (EPA recommendation 
n.414) and referred from mental health services (in line with the psychometric 
properties of the CHR instruments9), in particular, from early intervention for 
psychosis services. This brings the CHR paradigm back to its origin. In the first 
months of operation (1996), the original CHR clinic (the PACE) received the majority 
of referrals from the local early intervention for psychosis clinic (the EPPIC). As 
noted by the authors, the early intervention service ‘was an important factor’ (page 
292 from reference43) in the recruitment process. Our results also provide scientific 
support for the new AWT standards in the UK2, which require CHR assessment to be 
offered to all subjects accessing early intervention for psychosis services. 
 
Age had no impact on pre-test probability. Meta-analytical evidence indicates that the 
incidence of psychosis increases from childhood to the age of 20 to 24, then decreases 
over time (with a age x gender interaction, from figure S4 in reference 13). It is 
possible that we did not have enough power to detect significant age effects in the 
younger subgroup (there were only 30 subjects <16 years in our sample). We also 
found no effect of referral year on pre-test psychosis risk, suggesting no changes in 
the patterns of risk enrichment over time. Meta-analyses confirmed no change in the 
incidence of psychotic disorders over the past decades13. 
 
In the third aim of this study, we developed and externally validated a prognostic 
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model to stratify pre-test probability of psychosis onset in subjects undergoing a CHR 
assessment. The final model was based on simple variables that are easily collected in 
clinical practice and defined four distinct classes of pre-test risk: low, moderately low, 
moderately high and high. The high-risk class was also distinct with respect to shorter 
time to transition. Because the discrimination power of our model was only 
moderately good44 (different c-statistics can yield values that are as far as 0.10 
apart45), sequential testing after initial pre-test risk stratification is required. This may 
involve an initial CHR assessment to rule out psychosis (on the basis of the large 
negative likelihood ratio of 0.09 yielded by CHR instruments9) and potential 
additional testing based on more sophisticated neurobiological models. The 
theoretical potentials of sequential testing in subjects undergoing CHR assessment 
have been recently illustrated by our group46. Pre-test risk estimates and sequential 
testing have been used since the 1980’s47 in cardiovascular medicine and are still part 
of the clinical routine to guide and inform further testing and tailored treatments48, for 
example in patients with suspected coronary artery disease49 (e.g. those with chest 
pain). These patients should receive a thorough history and physical examination to 
assess the probability of ischemic heart disease ‘before additional testing’50. Similarly, 
stratification of low, intermediate and high pre-test probability of recent onset chest 
pain is currently being recommended by the NICE clinical guidelines (CG95 1.3.3, 
reproduced in eTable 4). As in the current study, the most widely used parameters are 
based on simple clinical variables such as the patient’s history51, the description of 
chest pain, sex and age (table 3 from47, eTable 4). For the low-risk population, 
exercise treadmill testing alone is frequently sufficient; however, in patients with a 
moderate to high risk for coronary artery disease, additional specific testing is usually 
required50,52. 
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Because services and referral patterns are heterogeneous11 and likely to be influenced 
by national and local factors, clinical validity of our model should be confirmed and 
refined by external replication studies conducted in other clinical scenarios. To 
facilitate this we provided the required statistical information (e.g. eTable 3, eFigure 
2) as recommended by international guidelines26. Other relevant limitations of this 
study are related to the use of the clinical case register and are fully discussed in the 
supplementary material (eLimitations).  
 
CONCLUSIONS 
There is substantial risk enrichment during the recruitment of subjects undergoing 
CHR assessment. Ethnicity and source of referral are predictors of pre-test risk 
enrichment. A pre-test risk stratification model has been developed and externally 
validated, which may inform outreach campaigns, help to optimize subsequent testing 
and the prediction of psychosis. 
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Table 1. Sociodemographic characteristics of subjects undergoing CHR 
assessment at the OASIS clinic (n=710) 
    N Mean SD 
Age (years)(a) 710 23.11 5.37 
Index of multiple deprivation (IMD) 710 31.96 8.45 
    N Count % 
Gender 710 
  
 
Males 
 
399 56.20 
 
Females 
 
311 43.80 
Ethnicity 660 
  
 
Black 
 
158 23.94 
 
White 
 
329 49.85 
 
Asian 
 
30 4.55 
 
Caribbean 
 
32 4.85 
 
Mixed 
 
35 5.30 
 
Other 
 
76 11.52 
Marital status 627 
  
 
Married 
 
19 3.03 
 
Divorced or separated 
 
19 3.03 
 
Single 
 
572 91.23 
 
In a relationship 
 
17 2.71 
Referral year 710 
  
 
2002-2005  
 
40 5.63 
 
2006-2010 
 
251 35.35 
 
2011-2015 
 
419 59.01 
Referral source 710 
  
 
Self 
 
66 9.30 
 
Carers or relatives 
 
13 1.83 
 
Schools or colleges 
 
6 0.85 
 
Social services or supported accomodation 
 
11 1.55 
 
General medical practitioners 
 
243 34.23 
 
Community mental health services 
 
165 23.24 
 
  Child and adolescent mental health services 61 8.59 
 
Early intervention for psychosis services 
 
47 6.62 
 
Accident and Emergency departments 
 
46 6.48 
 
Inpatient mental health services 
 
14 1.97 
 
Police and criminal justice system 
 
7 0.99 
  Physical health services   31 4.37 
Borough    
 Lambeth  321 45.21 
 Other (c)  389 54.79 
(a) age was used as continuous variable, for descriptive purposes only we 
report here that 30 subjects were under the age of 16 and 680 over the 
age of 16; (c) Croydon (27), Lewisham (84), Southwark (245) and other 
areas in Greater London (n=33). 
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Figure 1. Cumulative incidence (Kaplan-Meier failure function) for the pre-test 
probability of developing psychosis in subjects undergoing CHR assessment (n=710).   
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Figure 2. Cumulative incidence (Kaplan-Meier failure function) for risk classes of 
prognostic index of pre-test probability of psychosis onset in subjects undergoing 
CHR assessment, model updated in the whole sample.  
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Table 2 Classification of pre-test risk of psychosis in subjects undergoing CHR assessment  
 
                            Risk class of the prognostic index 
Characteristics 
Low pre-test risk Moderately low pre-test 
risk 
Moderately high pre-test 
risk 
High pre-test risk 
Prognostic score <-.644 >= -0.644 and <0.203 >= 0.203 and <0.555 >0.555 
% of patients  21.06% 52.58% 21.36% 5% 
Estimated time to transition, mean 
(95%CI), days 4067 (3955-4179) 4500 (4328-4672) 3842 (3501-4182) 2017 (1404-2631) 
Cumulative incidence, mean (95% CI) 
    At month 6 1.45% (0.3% - 5.69%) 4.36% (2.65% - 7.12%) 7.89% (4.45% - 13.79%) 21.21% (10.73% - 39.41%) 
At year 1 1.45% (0.3% - 5.69%) 6.58% (4.38% - 9.82%) 10.19% (6.16% - 16.61%) 27.78% (15.51% - 46.66%) 
Ay year 2 1.45% (0.3% - 5.69%) 8.16% (5.61% - 11.8%) 18.11% (12.37% - 26.09%) 34.66% (20.83% - 53.94%) 
At year 3 1.45% (0.3% - 5.69%) 9.97% (7.02% - 14.04%) 18.11% (12.37% - 26.09%) 45.55% (29.82% - 64.77%) 
At year 4 1.45% (0.3% - 5.69%) 9.97% (7.02% - 14.04%) 19.30% (13.28% - 27.57%) 53.65% (36.78% - 72.46%) 
At year 5 1.45% (0.3% - 5.69%) 10.58% (7.48% - 14.86%) 23.69% (16.58% - 33.20%) 53.65% (36.78% - 72.46%) 
At year 6 (b) 3.39% (0.96% - 11.56%) 11.58% (8.10%-16.40%) 23.69% (16.58% - 33.20%) 53.65% (36.78% - 72.46%) 
Moderately low pre-test risk vs low pre-test risk, HR 4.482, SE 2.706; Moderately high pre-test risk vs low pre-test risk HR 9.589, SE 5.836; High pre-test risk vs low 
pre-test risk HR=27.669, SE= 17.410; Moderately high pre-test risk vs moderately low pre-test risk, HR=2.139, SE= .559; High pre-test risk vs moderately low pre-test 
risk HR= 6.172   SE=1.890; High pre-test risk vs moderately high pre-test risk HR=2.885, SE= .911; (b) cumulative incidence was censored at the time of the last 
failure (2192 days), when 193 subjects were still at risk. 
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Figure 3. Pre-test risk of psychosis in subjects undergoing CHR assessment in South 
London and in the local age-matched general population. Crude incidence rates for 
the local population of 16-35 year were estimated with PsyMaptic v.1.0 
(http://www.psymaptic.org/) across the borough of Lambeth, Lewisham, Croydon, 
Southwark.  
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